Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
AB ›
ABANTRA
Trademark search for:
ABANTRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2010-03-12 — Application filed
2010-03-16 — Application filed
2010-03-17 — Application filed
2010-05-06 — Priority action written
2010-05-06 — Priority action e-mailed
2010-05-06 — Notification of priority action e-mailed
2010-05-06 — Assigned to examiner
2010-09-07 — Teas/email correspondence entered
2010-09-07 — Office action issued
2010-09-07 — Correspondence received in law office
2010-09-08 — Approved for pub - principal register
2010-09-16 — Assigned to lie
2010-09-16 — Law office publication review completed
2010-10-19 — Published for opposition
2010-10-19 — Official gazette publication confirmation e-mailed
2010-12-14 — Noa e-mailed - sou required from applicant
2011-04-12 — Sou teas extension received
2011-04-12 — Sou extension 1 filed
2011-04-12 — Sou extension 1 granted
2011-04-14 — Notice of approval of extension request e-mailed
2011-12-14 — Sou teas extension received
2011-12-14 — Sou extension 2 filed
2012-01-12 — Case assigned to intent to use paralegal
2012-01-12 — Sou extension 2 granted
2012-01-13 — Notice of approval of extension request e-mailed
2012-06-13 — Sou teas extension received
2012-06-13 — Teas change of owner address received
2012-06-13 — Sou extension 3 filed
2012-06-13 — Applicant/correspondence changes (non-responsive) entered
2012-06-14 — Sou extension 3 granted
2012-06-15 — Notice of approval of extension request e-mailed
2013-01-14 — Application abandoned
2013-01-14 — Application abandoned
2013-01-14 — Final status recorded
2014-03-12 — Assignment of ownership not updated automatically
Owner Information
Endo Pharmaceuticals Inc.
Endo Pharmaceuticals Inc.
Correspondent
JAMES R. MEYER SCHNADER HARRISON SEGAL & LEWIS LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
